| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 9 |
| GO:0110165 | cellular anatomical entity | 1 | 9 |
Related structures:
AlphaFold database: A4HEE4
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.559 |
| CLV_NRD_NRD_1 | 146 | 148 | PF00675 | 0.520 |
| CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.538 |
| CLV_NRD_NRD_1 | 86 | 88 | PF00675 | 0.557 |
| CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.559 |
| CLV_PCSK_KEX2_1 | 146 | 148 | PF00082 | 0.531 |
| CLV_PCSK_KEX2_1 | 245 | 247 | PF00082 | 0.370 |
| CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.597 |
| CLV_PCSK_PC1ET2_1 | 245 | 247 | PF00082 | 0.359 |
| CLV_PCSK_SKI1_1 | 112 | 116 | PF00082 | 0.611 |
| CLV_PCSK_SKI1_1 | 13 | 17 | PF00082 | 0.613 |
| CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.460 |
| CLV_PCSK_SKI1_1 | 26 | 30 | PF00082 | 0.588 |
| CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.472 |
| CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.550 |
| DEG_APCC_DBOX_1 | 145 | 153 | PF00400 | 0.307 |
| DEG_SCF_FBW7_1 | 121 | 128 | PF00400 | 0.420 |
| DOC_CKS1_1 | 122 | 127 | PF01111 | 0.348 |
| DOC_CKS1_1 | 42 | 47 | PF01111 | 0.390 |
| DOC_MAPK_gen_1 | 161 | 170 | PF00069 | 0.391 |
| DOC_MAPK_gen_1 | 251 | 261 | PF00069 | 0.610 |
| DOC_MAPK_gen_1 | 35 | 41 | PF00069 | 0.327 |
| DOC_MAPK_gen_1 | 63 | 69 | PF00069 | 0.237 |
| DOC_MAPK_gen_1 | 8 | 17 | PF00069 | 0.409 |
| DOC_PP1_RVXF_1 | 11 | 18 | PF00149 | 0.409 |
| DOC_PP4_FxxP_1 | 122 | 125 | PF00568 | 0.408 |
| DOC_PP4_FxxP_1 | 169 | 172 | PF00568 | 0.300 |
| DOC_USP7_MATH_1 | 142 | 146 | PF00917 | 0.411 |
| DOC_USP7_UBL2_3 | 254 | 258 | PF12436 | 0.652 |
| DOC_WW_Pin1_4 | 121 | 126 | PF00397 | 0.342 |
| DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.390 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.420 |
| LIG_BRCT_BRCA1_1 | 165 | 169 | PF00533 | 0.321 |
| LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.335 |
| LIG_EH_1 | 74 | 78 | PF12763 | 0.431 |
| LIG_eIF4E_1 | 221 | 227 | PF01652 | 0.358 |
| LIG_FHA_1 | 193 | 199 | PF00498 | 0.324 |
| LIG_FHA_1 | 52 | 58 | PF00498 | 0.351 |
| LIG_FHA_1 | 7 | 13 | PF00498 | 0.375 |
| LIG_LIR_Apic_2 | 119 | 125 | PF02991 | 0.412 |
| LIG_LIR_Apic_2 | 166 | 172 | PF02991 | 0.309 |
| LIG_LIR_Apic_2 | 93 | 99 | PF02991 | 0.409 |
| LIG_LIR_Gen_1 | 93 | 102 | PF02991 | 0.383 |
| LIG_LIR_Nem_3 | 55 | 61 | PF02991 | 0.316 |
| LIG_LIR_Nem_3 | 72 | 77 | PF02991 | 0.384 |
| LIG_LIR_Nem_3 | 93 | 97 | PF02991 | 0.370 |
| LIG_NRBOX | 221 | 227 | PF00104 | 0.475 |
| LIG_PCNA_PIPBox_1 | 215 | 224 | PF02747 | 0.413 |
| LIG_PCNA_yPIPBox_3 | 213 | 222 | PF02747 | 0.341 |
| LIG_PTB_Apo_2 | 68 | 75 | PF02174 | 0.317 |
| LIG_PTB_Phospho_1 | 68 | 74 | PF10480 | 0.352 |
| LIG_SH2_PTP2 | 78 | 81 | PF00017 | 0.402 |
| LIG_SH2_STAT5 | 156 | 159 | PF00017 | 0.408 |
| LIG_SH2_STAT5 | 175 | 178 | PF00017 | 0.294 |
| LIG_SH2_STAT5 | 221 | 224 | PF00017 | 0.328 |
| LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.357 |
| LIG_SH2_STAT5 | 61 | 64 | PF00017 | 0.197 |
| LIG_SH2_STAT5 | 68 | 71 | PF00017 | 0.279 |
| LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.263 |
| LIG_SH2_STAT5 | 96 | 99 | PF00017 | 0.307 |
| LIG_SH3_3 | 154 | 160 | PF00018 | 0.416 |
| LIG_SH3_3 | 167 | 173 | PF00018 | 0.306 |
| LIG_SH3_3 | 39 | 45 | PF00018 | 0.319 |
| LIG_SH3_3 | 54 | 60 | PF00018 | 0.319 |
| LIG_TRFH_1 | 169 | 173 | PF08558 | 0.306 |
| LIG_WW_1 | 172 | 175 | PF00397 | 0.295 |
| MOD_CDK_SPK_2 | 41 | 46 | PF00069 | 0.390 |
| MOD_CK1_1 | 6 | 12 | PF00069 | 0.424 |
| MOD_CK2_1 | 194 | 200 | PF00069 | 0.243 |
| MOD_GSK3_1 | 121 | 128 | PF00069 | 0.391 |
| MOD_GSK3_1 | 190 | 197 | PF00069 | 0.350 |
| MOD_GSK3_1 | 202 | 209 | PF00069 | 0.346 |
| MOD_GSK3_1 | 37 | 44 | PF00069 | 0.389 |
| MOD_N-GLC_1 | 108 | 113 | PF02516 | 0.556 |
| MOD_N-GLC_2 | 212 | 214 | PF02516 | 0.584 |
| MOD_NEK2_1 | 130 | 135 | PF00069 | 0.404 |
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.398 |
| MOD_NEK2_1 | 4 | 9 | PF00069 | 0.416 |
| MOD_PKA_2 | 136 | 142 | PF00069 | 0.439 |
| MOD_PKA_2 | 37 | 43 | PF00069 | 0.374 |
| MOD_Plk_1 | 199 | 205 | PF00069 | 0.402 |
| MOD_Plk_4 | 125 | 131 | PF00069 | 0.423 |
| MOD_Plk_4 | 163 | 169 | PF00069 | 0.322 |
| MOD_Plk_4 | 171 | 177 | PF00069 | 0.291 |
| MOD_Plk_4 | 48 | 54 | PF00069 | 0.254 |
| MOD_ProDKin_1 | 121 | 127 | PF00069 | 0.347 |
| MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.389 |
| MOD_SUMO_for_1 | 116 | 119 | PF00179 | 0.426 |
| TRG_ENDOCYTIC_2 | 221 | 224 | PF00928 | 0.337 |
| TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.399 |
| TRG_ENDOCYTIC_2 | 78 | 81 | PF00928 | 0.363 |
| TRG_ENDOCYTIC_2 | 94 | 97 | PF00928 | 0.177 |
| TRG_ER_diArg_1 | 112 | 114 | PF00400 | 0.380 |
| TRG_ER_diArg_1 | 146 | 148 | PF00400 | 0.243 |
| TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.418 |
| TRG_NES_CRM1_1 | 104 | 119 | PF08389 | 0.266 |
| TRG_Pf-PMV_PEXEL_1 | 246 | 250 | PF00026 | 0.410 |
| TRG_Pf-PMV_PEXEL_1 | 26 | 31 | PF00026 | 0.596 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1HYG4 | Leptomonas seymouri | 80% | 100% |
| A0A0S4JRT7 | Bodo saltans | 49% | 100% |
| A0A1X0ND76 | Trypanosomatidae | 61% | 100% |
| A0A3Q8ICJ6 | Leishmania donovani | 88% | 100% |
| A0A3R7N4J0 | Trypanosoma rangeli | 61% | 100% |
| C9ZKA0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
| E9AHA2 | Leishmania infantum | 88% | 100% |
| E9AXX6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 100% |
| Q4Q9J6 | Leishmania major | 88% | 100% |
| V5B2F8 | Trypanosoma cruzi | 61% | 100% |